ABSTRACT

The Handbook of Systemic Drug Treatment in Dermatology helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. Written for dermatologists, family practitioners, pharmacists and specialist nurses, this completely revised and updated third edition of a bestseller provides an accessible and concise aid to prescribing and monitoring systemic dermatologic therapy. For each drug or drug class, the book lists its classification, mode of action, formulations, dosages, suggested regimens, contraindications, important drug interactions, adverse effects, patient information, and more. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.

FROM REVIEWS OF PREVIOUS EDITIONS

"This updated edition includes new arrivals… Quite simply, it is indispensable! I have it with me in every clinic and often refer to it in discussions with pharmacists (who have been known to borrow my copy and forget to return it)." Dermatology in Practice

"... an outstanding resource that helps to alleviate worrying by providing precise guidelines and advice in managing our most infirm patients who require these medications." SkinMed

chapter 1|5 pages

Acitretin

chapter 3|6 pages

Alitretinoin

chapter 4|9 pages

Antiandrogens

chapter 6|19 pages

Antifungals

chapter 7|6 pages

Antimalarials

chapter 8|7 pages

Antivirals for Herpesviruses

chapter 9|4 pages

Apremilast

chapter 10|6 pages

Azathioprine

chapter 11|4 pages

Azole Antihelminths

chapter 12|5 pages

Bexarotene

chapter 13|6 pages

Ciclosporin

chapter 14|5 pages

Colchicine

chapter 15|8 pages

Corticosteroids

chapter 16|8 pages

Cyclophosphamide

chapter 17|6 pages

Dapsone

chapter 18|5 pages

Dimethyl Fumarate

chapter 19|6 pages

Interleukin-4/13 Inhibitors

chapter 22|8 pages

Isotretinoin

chapter 23|5 pages

Ivermectin

chapter 24|6 pages

Intravenous Immunoglobulin

chapter 27|8 pages

Methotrexate

chapter 29|4 pages

Omalizumab

chapter 30|3 pages

Potassium Iodide

chapter 31|5 pages

Propranolol

chapter 32|8 pages

Psoralens

chapter 33|5 pages

Rituximab

chapter 35|6 pages

Thalidomide

chapter 37|4 pages

Vismodegib

chapter 39|4 pages

Systemic Therapy and Kidney Disease